EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE
Objectives: To determine the frequency of early molecular response in patients of chronic myeloid leukemia treated with Imatinib and its association with baseline white blood cell (WBC) count and spleen size. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hosp...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Army Medical College Rawalpindi
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/d08677138f37425ea0848e8e5bae5e9c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|